ArticleFrontiers in immunology2026
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Graves' orbitopathy (GO) is a complication of Graves' disease characterized by periorbital tissue inflammation, adipose tissue expansion, and fibrosis. The infiltration of immune cells into the periorbital tissue is thought to be a crucial factor in triggering the complication. Although orbital fibroblasts are considered to represent key cellular elements in the pathogenesis of GO, their interaction with immune cells is hardly explored. Here, we aimed to study Methods: Orbital fibroblasts and PBMCs collected from active and inactive GO patients were co-cultured for 48 h in the presence of vitamin D3 and/or steroids (methylprednisolone, MP). Flow cytometric, quantitative PCR (qPCR), and immunoenzymatic assessments enabled evaluation of the changes during cell-to-cell interactions. Results: We found that orbital fibroblasts from inactive GO exhibited higher expression of the genes associated with tissue remodeling. Co-culture of fibroblasts with PBMCs enhanced the proliferation rate of fibroblasts, especially the fibroblasts from active GO. Moreover, the cytokine secretion patterns and early changes in the deposition of extracellular matrix compounds by orbital fibroblasts were also found to differ between disease stages. In addition, we demonstrate that exposure to MP reduces fibroblast proliferation, particularly those derived from the inactive disease stage, and that the combination of MP with vitamin D3 suppresses IL-6 and CCL-20 secretion. Conclusion: We propose that the pathogenesis of GO involves mutual interactions between orbital fibroblasts and immune cells, which may be disease stage-specific and can be modulated by MP and vitamin D3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.